BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30741261)

  • 1. An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay.
    Do LAH; Tse R; Nathanielsz J; Anderson J; Ong DS; Chappell K; Mulholland K; Licciardi PV
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30741261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimized high-throughput fluorescence plate reader-based RSV neutralization assay.
    Sun YP; Zhang W; Zhao QJ; Cao JL; Zhang LJ; Xiang JY; Si JY; Lin X; Chen L; Zheng ZZ; Xia NS
    J Virol Methods; 2018 Oct; 260():34-40. PubMed ID: 30003925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging.
    Wen Z; Citron M; Bett AJ; Espeseth AS; Vora KA; Zhang L; DiStefano DJ
    J Virol Methods; 2019 Jan; 263():88-95. PubMed ID: 30381239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay.
    Shambaugh C; Azshirvani S; Yu L; Pache J; Lambert SL; Zuo F; Esser MT
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSV neutralization assays - Use in immune response assessment.
    Raghunandan R; Higgins D; Hosken N
    Vaccine; 2021 Jul; 39(33):4591-4597. PubMed ID: 34244007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Gerretsen HE; Capone S; Vitelli A; Reyes LS; Thompson A; Jones C; Green CA; Pollard AJ; Sande CJ
    Vaccine; 2018 Nov; 36(46):6988-6994. PubMed ID: 30318168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard.
    Hosken N; Plikaytis B; Trujillo C; Mahmood K; Higgins D;
    Vaccine; 2017 May; 35(23):3082-3088. PubMed ID: 28476625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
    Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
    Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.
    Luchsinger V; Piedra PA; Ruiz M; Zunino E; Martínez MA; Machado C; Fasce R; Ulloa MT; Fink MC; Lara P; Avendaño LF
    Clin Infect Dis; 2012 Apr; 54(7):905-12. PubMed ID: 22238168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of complement in neutralization of respiratory syncytial virus.
    Yoder SM; Zhu Y; Ikizler MR; Wright PF
    J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
    Lee JY; Chang J
    J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and qualification of a fast, high-throughput and robust imaging-based neutralization assay for respiratory syncytial virus.
    Sun D; Hsu A; Bogardus L; Rubinstein LJ; Antonello JM; Gurney KB; Whiteman MC; Dellatore S
    J Immunol Methods; 2021 Jul; 494():113054. PubMed ID: 33845088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity.
    Leemans A; Boeren M; Van der Gucht W; Martinet W; Caljon G; Maes L; Cos P; Delputte P
    Virus Res; 2019 Jun; 266():58-68. PubMed ID: 31004621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate.
    Chen M; Chang JS; Nason M; Rangel D; Gall JG; Graham BS; Ledgerwood JE
    J Immunol Methods; 2010 Oct; 362(1-2):180-4. PubMed ID: 20727896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting.
    van Remmerden Y; Xu F; van Eldik M; Heldens JG; Huisman W; Widjojoatmodjo MN
    Virol J; 2012 Oct; 9():253. PubMed ID: 23114196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897.
    Zhu Q; Lu B; McTamney P; Palaszynski S; Diallo S; Ren K; Ulbrandt ND; Kallewaard N; Wang W; Fernandes F; Wong S; Svabek C; Moldt B; Esser MT; Jing H; Suzich JA
    J Infect Dis; 2018 Jul; 218(4):572-580. PubMed ID: 29617879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.